| Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity S Raghavan, P Mehta, EN Horst, MR Ward, KR Rowley, G Mehta Oncotarget 7 (13), 16948, 2016 | 180 | 2016 |
| Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments S Raghavan, P Mehta, Y Xie, YL Lei, G Mehta Journal for immunotherapy of cancer 7, 1-15, 2019 | 173 | 2019 |
| Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer JR Brown, DK Chan, JJ Shank, KA Griffith, H Fan, R Szulawski, K Yang, ... JCI insight 5 (11), 2020 | 135 | 2020 |
| Personalized medicine–based approach to model patterns of chemoresistance and tumor recurrence using ovarian cancer stem cell spheroids S Raghavan, P Mehta, MR Ward, ME Bregenzer, EMA Fleck, L Tan, ... Clinical Cancer Research 23 (22), 6934-6945, 2017 | 92 | 2017 |
| Integrated cancer tissue engineering models for precision medicine ME Bregenzer, EN Horst, P Mehta, CM Novak, S Raghavan, CS Snyder, ... PLoS One 14 (5), e0216564, 2019 | 77 | 2019 |
| The hepatoprotective potential of Spirulina and vitamin C supplemention in cisplatin toxicity S Bhattacharyya, P Mehta Food & function 3 (2), 164-169, 2012 | 67 | 2012 |
| The role of cancer stem cells and mechanical forces in ovarian cancer metastasis ME Bregenzer, EN Horst, P Mehta, CM Novak, T Repetto, G Mehta Cancers 11 (7), 1008, 2019 | 61 | 2019 |
| Structure-based optimization of a novel class of aldehyde dehydrogenase 1A (ALDH1A) subfamily-selective inhibitors as potential adjuncts to ovarian cancer chemotherapy BC Huddle, E Grimley, CD Buchman, M Chtcherbinine, B Debnath, ... Journal of medicinal chemistry 61 (19), 8754-8773, 2018 | 59 | 2018 |
| Engineered 3D model of cancer stem cell enrichment and chemoresistance MRW Rashidi, P Mehta, M Bregenzer, S Raghavan, EM Fleck, EN Horst, ... Neoplasia 21 (8), 822-836, 2019 | 52 | 2019 |
| Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres P Mehta, C Novak, S Raghavan, M Ward, G Mehta Cancer Stem Cells, 61-75, 2018 | 37 | 2018 |
| Physiologic patient derived 3D spheroids for anti-neoplastic drug screening to target cancer stem cells ME Bregenzer, C Davis, EN Horst, P Mehta, CM Novak, S Raghavan, ... JoVE (Journal of Visualized Experiments), e59696, 2019 | 15 | 2019 |
| Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model EN Horst, ME Bregenzer, P Mehta, CS Snyder, T Repetto, ... Acta biomaterialia 132, 401-420, 2021 | 11 | 2021 |
| Novel Omniphobic Platform for Multicellular Spheroid Generation, Drug Screening, and On-Plate Analysis M Boban, P Mehta, AK Halvey, T Repetto, A Tuteja, G Mehta Analytical chemistry 93 (22), 8054-8061, 2021 | 5 | 2021 |
| Tumor modeling maintains diverse pathology in vitro ME Bregenzer, EN Horst, P Mehta, CM Novak, T Repetto, CS Snyder, ... Annals of Translational Medicine 7 (Suppl 8), 2019 | 4 | 2019 |
| Patient-specific evaluation of chemoresistance and tumor recurrence using ovarian cancer stem cell spheroids. S Raghavan, P Mehta, M Bregenzer, MW Rashidi, E Fleck, L Tan, ... CLINICAL CANCER RESEARCH 24 (15), 55-55, 2018 | | 2018 |
| Abstract A33: Patient-specific evaluation of chemoresistance and tumor recurrence using ovarian cancer stem cell spheroids S Raghavan, P Mehta, M Bregenzer, MW Rashidi, E Fleck, L Tan, ... Clinical Cancer Research 24 (15_Supplement), A33-A33, 2018 | | 2018 |
| Abstract AP22: CHEMORESISTANCE, TUMOR INITIATION AND TUMOR RE–EMERGENCE TRENDS IN MALIGNANT ASCITES–DERIVED OVARIAN CANCER STEM CELL SPHEROIDS S Raghavan, M Ward, P Mehta, RJ Buckanovich, G Mehta Clinical Cancer Research 23 (11_Supplement), AP22-AP22, 2017 | | 2017 |
| Use of 99mTc ethylene dicysteine in evaluating the protective efficacy of spirulina in cisplatin-induced nephrotoxicity S Bhattacharyya, P Mehta Journal of Nuclear Medicine 50 (supplement 2), 1404-1404, 2009 | | 2009 |
